Effect of Incentive Spirometery on Asthmatic Pregnant Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05904002

Enrollment

Registered

2023-06-15

Start date

2020-09-20

Completion date

2022-02-15

Last updated

2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthmatic, Pregnant With Complication

Brief summary

The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.

Detailed description

This study will provide an evidence basis for obstetricians and physical therapist for women's health about the effect of spirometry on asthma during pregnancy.

Interventions

DRUGpulmicort inhaler

Each woman in both groups (A&B) will receive pulmicort inhaler on needs.

DEVICEIncentive spirometer treatment

Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

30 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

The patients will have the following criteria: 1. Their age will range from 30 to40years old. 2. Body mass index (BMI) will range from 25-29.9 kg/m2. 3. All patients will be clinically and medically stable.

Exclusion criteria

Patients will be excluded from the study if they have the following: 1. Diabetes mellitus. 2. Severe hypertension. 3. Neurological and neuromuscular disorders. 4. Blindness. 5. Developed moderate and severe degree of pleural effusion. 6. Cardiovascular instability. 7. Chronic chest disease.

Design outcomes

Primary

Measure	Time frame	Description
Assessing the change in lung functions	at baseline and after 6 weeks of intervention	The spirometer will be used for assessment of lung functions including total lung capacity (TLC) (litre), which is the most widely used functional index in the asthma follow up.
Assessing the change in symptoms of asthma	at baseline and after 6 weeks of intervention	The Asthma Control Test provides a numerical score to help you and your healthcare provider determine if your asthma symptoms are well controlled. Take this test if you are 12 years or older. Share the score with your healthcare provider.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026